Viewing Study NCT00458367

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:38 AM

Ignite Modification Date: 2025-12-25 @ 10:48 PM

Study NCT ID: NCT00458367

Status: COMPLETED

Last Update Posted: 2010-10-18

First Post: 2007-04-06

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice

Sponsor: Janssen Pharmaceutica N.V., Belgium

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module